Dr. Mira Chaurushiya is a Senior Partner at Westlake Village BioPartners. As a biologist who worked in industry research before entering the venture capital industry, she has a long and successful track record in both biological sciences and life-sciences investing. Dr. Chaurushiya is a fellow of the Society of Kauffman Fellows. After a postdoctoral fellowship in physiological chemistry at Genentech, she joined 5AM Ventures as an associate and took on positions of increasing responsibility, culminating as a partner. During her tenure at 5AM Ventures, she invested in and served as director or observer on the boards of multiple organizations, including Precision Nanosystems (acquired by Danaher), Ideaya Biosciences (IDYA), Enliven Therapeutics, Escient Pharmaceuticals, Magnetic Insight, Novome Biotechnologies, Purigen Biosystems, NodThera and TMRW. Dr. Chaurushiya received her Ph.D. in biological sciences from the University of California, San Diego in conjunction with the Salk Institute for Biological Studies, where she was awarded the Martin Kamen Thesis Prize in Biochemistry. She received her bachelor's degree in biology from Carleton College. She serves on the board of Biotech Connection Bay Area, a non-profit that focuses on career development for academic scientists.